KidneyCAN shared on LinkedIn:
“Huge shoutout to our KCRS24 Research Partners: AVEO Oncology and Merck.
Your commitment to accelerating cures for kidney cancer is making a real impact. Here’s to more breakthroughs and lives saved!”
Source: KidneyCAN/LinkedIn